Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Inclusion Criteria

• •Participants must have met all of the following criteria to be included in this study:
• •1. Diagnosis of epilepsy
• •2. Initiated treatment with Fycompa at any time after 01 Jan 2014
• •3. Provided written informed consent by the participant or the participant's legally authorized representative signed for the use of medical records (if required by an Institutional Review Board \[IRB\] or Independent Ethics Committee \[IEC\], or by regulatory authorities).